MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹47.75 | ₹32.00 | ₹35.78 | ₹31.59 | ₹25.72 |
What is the latest Earnings Per Share (EPS) of MANKIND PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹47.75 |
| Mar2024 | ₹32.00 |
| Mar2023 | ₹35.78 |
| Mar2022 | ₹31.59 |
| Mar2021 | ₹25.72 |
How is Earnings Per Share (EPS) of MANKIND PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹47.75 | 49.22 | |
| Mar2024 | ₹32.00 | -10.56 | |
| Mar2023 | ₹35.78 | 13.26 | |
| Mar2022 | ₹31.59 | 22.82 | |
| Mar2021 | ₹25.72 | - | |
Compare Earnings Per Share (EPS) of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹102,419.8 Cr | -0.6% | 11% | -1.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.6% |
11% |
-1.8% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses